| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851532 | American Journal of Kidney Diseases | 2008 | 10 Pages |
Abstract
Iron depletion and associated relative thrombocytosis might contribute to increased mortality when administering high rHuEPO doses to achieve hemoglobin levels of 13 g/dL or greater in long-term hemodialysis patients. Randomized trials are needed to test these observational associations.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Elani MPH, Csaba P. MD, Sander DrPH, Joel D. MD, Charles J. MD, Allen R. MD, Kamyar MD, MPH, PhD,